LRRK2 and Parkinson disease: High heterogeneity was discovered in the risk and severity of RBD in patients with PD carrying LRRK2 variants (risk of RBD, I2 = 71.7%, P = 0.000; severity of RBD, I2 = 78.6%, P = 0.000).